Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia

Circulation

Volumn 97, Issue 18, 1998, Pages 1780-1783

  O'Malley, Jean P ^b   Maslen, Cheryl L ^b   Illingworth, D Roger ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

Angiotensin; Coronary disease; Hypercholesterolemia; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN B100; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0032510650     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.18.1780     Document Type: Article

References (25)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
2. Nielsen L, Slender S, Kjeldsen K, Nordestgaard B. Effect of angiotensin and enalapril on transfer of low-density lipoprotein into aortic intima in rabbits. Circ Res. 1994;75:63-69.
3. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
4. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Laiouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91:2120-2124.
5. Leatham E, Barley J, Redwood S, Hussein W, Carter N, Jeffrey S, Both PM, Camm A. Angiotensin-I converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens. 1994;8:635-638.
6. Zhao Y, Higashimori K, Higaki J. Significance of deletion polymorphism of the angiotensin-converting enzyme gene as a risk factor of myocardial infarction in Japanese. Hypertens Res. 1994;17:55-57.
7. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion polymorphism at the locus for angiotensin-I converting enzyme and myocardial infarction. Clin Genet. 1993;44:292-297.
8. Lindpaintner J, Pfeffer MA, Kreutz R. A prospective evaluation of the angiotensin-converting enzyme gene polymorphism and the risk of ische mic heart disease. N Engl J Med. 1995;332:706-711.
9. Katsuya T, Koike G, Yee TW, Sharp N, Jackson R, Norton R, Hariuchi M, Pratt Re, Ozou VJ, McMahon S. Association of angiotensin gene T235 variant with increased risk of coronary heart disease. Lancet. 1995;345:1600-1603.
10. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme gene polymorphism: what to do about all the confusion? Circulation. 1996;94:236-239.
11. Castellano M, Muiesan ML, Rizzoni D, Pasini G, Cinelli A, Salvetti M, Porteri E, Bettoni G, Kreutz R, Lindpainter K, Rosei EA. Angiotensinconverting enzyme I/D polymorphism and arterial wall thickness in a general population: the Vobarno study. Circulation. 1995;91:2721-2724.
12. Bonithon-Kopp C, Ducimetiere P, Toubol P-J, Feve JM, Billaud E, Courbon D, Heraud V. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation. 1994;89:952-954.
13. Amant C, Bauters C, Bodart J-C, Lablanche J-M, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P, Bertrand ME. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997;96:56-60.
14. Samani N, Thompson JR, O'Toole L, Channer K, Woods KL. A metaanalysis of the association of the deletion allele of the angiotensinconverting enzyme gene with myocardial infarction. Circulation. 1996;94:708-712.
15. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwick D, Harley A, Swales JD, deBono DP, Gershlick AH. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet. 1995;345:1013-1016.
16. Mabuchi H, Koizumi J, Shimizu M, Takeda R. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989;79:225-232.
17. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990;322:1494-1499.
18. Defesche JC, Pricker KL, Hayden MR, Vanderende BE, Kasteleine JJP. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia. Arch Intern Med. 1993;53:2349-2356.
19. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990;264:3007-3012.
20. Bell G, Karam J, Rutter W. Polymorphic DNA region adjacent to the 5 end of the human insulin gene. Proc Natl Acad Sci USA. 1981;78:5759-5763.
21. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin I-converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
22. Shanmugan V, Sell KW, Saha BK. Mistype ACE heterozygotes. PCR Methods, Applications. 1993;3:120-121.
23. Howell DC. Statistical Methods for Psychology. Boston, Mass: PWS-Kent Publishing Co; 1992.
24. Fuster V, Badimon JJ. Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the angiogram. Eur Heart J. 1995;16(suppl. E):6-12.
25. Daeman MJP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.